Merck Announces Launch of Pioneering Collaborative Cancer Trials Network
- Details
- Category: Merck

FDA Approves Amgen's Prolia(TM) (Denosumab) for Treatment of Postmenopausal Women with Osteoporosis
- Details
- Category: Amgen

Victoza® to be launched in Japan in June
- Details
- Category: Novo Nordisk

AstraZeneca Receives FDA Complete Response Letter for AXANUM New Drug Application
- Details
- Category: AstraZeneca

Sanofi-aventis and Generics Leader Nichi-Iko to Establish New Joint Venture for Generics in Japan
- Details
- Category: Sanofi

Novartis announces extension of US regulatory priority review period for FTY720
- Details
- Category: Novartis

Results of the clinical study CALYPSO Published in The Journal of Clinical Oncology
- Details
- Category: Merck

More Pharma News ...
- Genzyme Receives FDA Approval for Lumizyme for Pompe Disease
- European Medicines Agency maintains position on the continued use of Rotarix
- Ranibizumab significantly more effective than standard of care in treating vision loss due to DME
- Abbott to Become No. 1 Pharmaceutical Company in India
- Pfizer Global Manufacturing Announces Plans to Reconfigure its Global Plant Network
- Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.
- Sanofi-aventis Announces the Creation of the "Sanofi Espoir" Corporate Foundation